-
Pharmacology
-
- Enzymes
-
- ATPase & GTPase
- Caspase
- Cholinesterase
- Coenzymes
- Cyclase
- Cyclooxygenase
- Cytochrome P450
- Deacetylase
- Dehydrogenase
- Demethylase
- Hydrolase
- Isomerase
- Kinase
- Oxidases
- Oxygenase
- Phosphatase
- Phosphodiesterase
- Phospholipase & Lipase
- Polymerase
- Protease
- Reductase
- Secretase
- Synthetase & synthase
- Telomerase
- Transaminase
- Transferase
- Ion Channels
- - Receptors & Transporters
-
- Adenosine
- Adrenoceptors
- Cannabinoid
- Catalytic Receptors
- Chemokine
- Dopamine
- Enzyme-Linked Receptors
- G protein-coupled estrogen
- GABA
- Glutamate
- Glycine
- Histamine
- Imidazoline
- Inositol triphosphate receptor
- Melatonin
- Muscarinic
- Nicotinic
- Nuclear Receptors
- Opioids
- - Peptide Receptors
-
- Angiotensin
- Apelin
- AXOR
- Bombesin
- Bradykinin
- CCK
- Endothelin
- Galanin
- Ghrelin
- Glucagon and Related Receptors
- LHRH
- Melanocortin
- Melanocyte Stimulating Hormone
- Motilin
- Neuromedin
- Neuropeptide FF/AF Receptors
- Neuropeptide S
- Neuropeptide Y
- Neurotensin
- Orexin
- Other
- Oxytocin
- PAR
- Secretin receptor
- Sensory Neuron Specific Receptor
- Somatostatin
- Substance P
- Tachykinins
- Vasopressin
- VIP
- Prostanoid
- Purinergics
- Serotonin
- Sigma
- Smoothened
- Sphingosine 1-Phosphate Receptors
- TGR5
- Toll-like Receptors
- Transporters
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Epigenetics
- Extracellular matrix & cell adhesion
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
-
Research Area
-
- Addiction
- Alzheimer's Disease
-
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Muscarinic
- Nicotinic
- Nitric oxide signaling
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Cancer
-
- Angiogenesis
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Epigenetics
- Extracellular matrix & cell adhesion
- Nuclear Receptors
- Signal transduction
- Depression
- Diabetes
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Heart disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Calcium
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Hypertension
-
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Obesity
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Serotonin
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Pain & inflammation
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- GABA
- Glutamate
- Histamine
- Immunomodulators
- Nitric oxide signaling
- Opioids
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Parkinson's Disease
- Respiratory disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Histamine
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Schizophrenia
- Stress / Anxiety
- Stroke
-
- Adenosine
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
We have 80 products in: Biochemicals >> Pharmacology >> Receptors & Transporters >> Peptide Receptors
Peptide Receptors |
| - page: 1 2 |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| (PAC)1 antagonist |   | ||
| (PAC)1 antagonist | | ||
| Selective melanocortin 3 (MC3) receptor agonist Purity: > 98% | | ||
| Selective melanocortin receptor 3 (MC3) agonist Purity: > 98% | | ||
| Potent, endogenous melanocortin receptor 2 (MC2) agonist Purity: > 98% | | ||
| Vasoconstrictor peptide Purity: > 95% | | ||
| Selective endogenous apelin receptor (APJ) ligand Purity: > 95% | | ||
| Highly potent, selective endogenous apelin receptor (APJ) agonist Purity: > 95% | | ||
| Endogenous apelin receptor (APJ) agonist Purity: > 95% | | ||
| Endogenous apelin receptor (APJ) agonist Purity: > 95% | | ||
| PAR4 agonist peptide Purity: > 95% | | ||
| SNSR agonist Purity: > 95% | | ||
| Potent, selective somatostatin receptor 5 (sst5) antagonist Purity: > 98% | | ||
| Selective somatostatin (sst5) receptor 5 agonist Purity: > 98% | | ||
| Potent, selective ETA receptor antagonist Purity: > 95% | | ||
| Bradykinin receptor agonist Purity: > 98% | | ||
| C-terminal ocatapeptide of CCK Purity: > 95% | | ||
| Potent selective somatostatin receptor 2 (sst2) antagonist Purity: > 98% | | ||
| Vasoconstrictor peptide Purity: > 97% | | ||
| Selective protease-activated receptor 2 (PAR2) anatagonist Purity: > 98% | | ||
| Potent GLP-1 receptor agonist Purity: > 99% | | ||
| Potent, selective GLP-1 receptor antagonist Purity: > 98% | | ||
| Galanin receptor peptide agonist Purity: > 98% | | ||
| N-terminal galanin fragment Purity: > 95% | | ||
| Non-selective galanin receptor agonist Purity: > 98% | | ||
| Endogenous galanin receptor agonist Purity: > 98% | | ||
| Selective CCK2 agonist Purity: > 97% | | ||
| Endogenous GHS agonist Purity: > 95% | | ||
| Endogenous GHS agonist Purity: > 95% |  | ||
| Truncated endogenous gastric inhibitory peptide (GIP) Purity: > 98% | | ||
| Endogenous gastric inhibitory peptide (GIP) Purity: > 98% | | ||
| Endogenous GRP receptor agonist Purity: > 95% | | ||
| AXOR12 agonist Purity: > 95% | | ||
| Somatostatin receptor analog Purity: > 98% | | ||
| Amphibian bombesin-like peptide Purity: > 99% | | ||
| Insect tachykinin-related peptide Purity: > 95% | | ||
| Selective non-peptide angiotensin II AT1 receptor antagonist Purity: > 99% | | ||
| Reproductive hormone Purity: > 95% | | ||
| Pro-opiomelanocortin (POMC) derived peptide Purity: > 98% | | ||
| Potent, selective GAL2 agonist Purity: > 98% | | ||
| Potent, non-selective galanin receptor antagonist Purity: > 98% | | ||
| Selective galanin GAL1 receptor agonist Purity: > 98% | | ||
| Selective galanin GAL2 receptor antagonist Purity: > 98% | | ||
| Inhibits α-MSH release; inhibits biological effect of opioids in vivo Purity: > 98% | | ||
| Gastrointestinal peptide and potent motilin receptor ligand Purity: > 98% | | ||
| Endogenous melanocortin receptor agonist Purity: > 95% | | ||
| Endogenous melanocortin receptor agonist Purity: > 95% | | ||
| Tachykinin peptide Purity: > 95% | | ||
| Bombesin-like peptide; endogenous ligand for the neuromedin B receptor Purity: > 98% | | ||
| Potent, neuromedin U (NMU) receptor agonist Purity: > 95% | | ||
| Endogenous neuropeptide with multiple biological effects Purity: > 95% | | ||
| NPS receptor agonist Purity: > 95% |  | ||
| NPS receptor agonist Purity: > 95% | | ||
| Endogenous anti-opiate neuropeptide. Purity: > 98% | | ||
| Endogenous neuropeptide Purity: > 95% | | ||
| NPY Y2 agonist Purity: > 95% | | ||
| Endogenous neuropeptide and endocrine modulator Purity: > 98% | | ||
| Endogenous peptide involved in feeding Purity: > 95% | | ||
| Somatostatin analog Purity: > 99% | | ||
| Neuropeptide involved in feeding and sleep Purity: > 99% | | ||
| Endogenous neuropeptide. OX2 agonist. Purity: > 95% | | ||
| Reproductive hormone Purity: > 95% | | ||
| Reproductive hormone Purity: > 95% | | ||
| CCKB receptor agonist | | ||
| Prolactin-releasing peptide Purity: > 98% | | ||
| Potent, selective ASIC1a blocker Purity: > 95% | | ||
| Selective, non-peptide OX1 antagonist Purity: > 98% | | ||
| Potent and selective PAR1 antagonist Purity: > 98% | | ||
| Endogenous secretin peptide Purity: > 98% | | ||
| Potent melanocortin 3 and 4 (MC3 and MC4) receptor antagonist Purity: > 99% | | ||
| PAR2 agonist peptide Purity: > 98% | | ||
| Endogenous neuropeptide Purity: > 98% | | ||
| Broad spectrum neuropeptide antagonist/inverse agonist Purity: > 99% | | ||
| Sensory neuropeptide Purity: > 95% | | ||
| Selective angiotensin II (AT1) antagonist Purity: > 99% | |
| Back to top | |
| - page: 1 2 |